Incidental Mutation 'R8038:Tab1'
ID 618358
Institutional Source Beutler Lab
Gene Symbol Tab1
Ensembl Gene ENSMUSG00000022414
Gene Name TGF-beta activated kinase 1/MAP3K7 binding protein 1
Synonyms 2310012M03Rik, Map3k7ip1, b2b449Clo, Tak1-binding protein 1
MMRRC Submission 067475-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R8038 (G1)
Quality Score 225.009
Status Validated
Chromosome 15
Chromosomal Location 80017333-80045908 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 80044471 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Alanine at position 500 (T500A)
Ref Sequence ENSEMBL: ENSMUSP00000023050 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000023050]
AlphaFold Q8CF89
PDB Structure Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) [X-RAY DIFFRACTION]
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) [X-RAY DIFFRACTION]
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate) [X-RAY DIFFRACTION]
Predicted Effect probably benign
Transcript: ENSMUST00000023050
AA Change: T500A

PolyPhen 2 Score 0.078 (Sensitivity: 0.93; Specificity: 0.85)
SMART Domains Protein: ENSMUSP00000023050
Gene: ENSMUSG00000022414
AA Change: T500A

DomainStartEndE-ValueType
PP2Cc 26 363 7.45e-40 SMART
low complexity region 397 408 N/A INTRINSIC
low complexity region 438 455 N/A INTRINSIC
PDB:4L3P|A 466 502 6e-17 PDB
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.8%
  • 20x: 99.3%
Validation Efficiency 100% (50/50)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous mutant fetuses exhibit edema, hemorrhaging, cardiovascular and pulmonary dysmorphogenesis, and die in the late stages of gestation. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 50 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acaca T A 11: 84,106,730 (GRCm39) M143K probably damaging Het
Accs A T 2: 93,673,262 (GRCm39) probably null Het
Alkbh5 T C 11: 60,429,811 (GRCm39) V188A probably damaging Het
Cacna1h C T 17: 25,594,865 (GRCm39) V2098I probably damaging Het
Chuk A G 19: 44,067,416 (GRCm39) Y580H probably damaging Het
Col7a1 A G 9: 108,786,360 (GRCm39) N530S unknown Het
Cops2 A T 2: 125,674,206 (GRCm39) H420Q probably benign Het
Ctcfl A T 2: 172,943,698 (GRCm39) C551S probably damaging Het
Depdc5 T C 5: 33,116,692 (GRCm39) probably null Het
Dnmt1 A C 9: 20,852,860 (GRCm39) V82G probably damaging Het
Fam90a1a A T 8: 22,453,455 (GRCm39) N270I possibly damaging Het
Foxn4 T C 5: 114,394,658 (GRCm39) D423G probably damaging Het
Hoxa5 A G 6: 52,181,309 (GRCm39) S8P probably damaging Het
Ighe A T 12: 113,233,053 (GRCm39) V456D Het
Ighv1-52 A G 12: 115,109,210 (GRCm39) F83S probably damaging Het
Itga2 A T 13: 114,990,291 (GRCm39) N921K probably damaging Het
Kdm2b T C 5: 123,098,958 (GRCm39) probably benign Het
Llgl2 T G 11: 115,741,929 (GRCm39) M657R probably benign Het
Lrrcc1 T A 3: 14,630,890 (GRCm39) I1019K possibly damaging Het
Lrriq3 A T 3: 154,869,638 (GRCm39) D321V probably benign Het
Lsm10 T C 4: 125,991,890 (GRCm39) V82A probably damaging Het
Mettl3 A G 14: 52,537,421 (GRCm39) S154P possibly damaging Het
Naip2 T C 13: 100,298,570 (GRCm39) I489V probably benign Het
Nat8f5 T A 6: 85,794,667 (GRCm39) T98S possibly damaging Het
Or10w1 G A 19: 13,632,719 (GRCm39) V309M possibly damaging Het
Or4c113 A T 2: 88,885,212 (GRCm39) L186Q probably damaging Het
Or7e166 G T 9: 19,624,976 (GRCm39) M284I possibly damaging Het
Or8d6 T A 9: 39,854,177 (GRCm39) V207D probably damaging Het
Pira1 C G 7: 3,740,319 (GRCm39) A301P probably damaging Het
Pld5 T C 1: 175,872,463 (GRCm39) I225V probably benign Het
Ppfia1 C A 7: 144,068,653 (GRCm39) A414S possibly damaging Het
Ppib T C 9: 65,967,615 (GRCm39) V23A probably benign Het
Rabggta A T 14: 55,956,387 (GRCm39) S361T probably benign Het
Rap1gap2 T C 11: 74,283,109 (GRCm39) S664G probably benign Het
Recql5 A G 11: 115,818,178 (GRCm39) V285A possibly damaging Het
Rtn4rl1 G C 11: 75,156,707 (GRCm39) E380Q possibly damaging Het
Scarb2 A T 5: 92,599,307 (GRCm39) S338T probably damaging Het
Skint4 T G 4: 111,977,003 (GRCm39) probably benign Het
Slc13a5 T C 11: 72,144,196 (GRCm39) K294R probably benign Het
Spib A G 7: 44,179,310 (GRCm39) F32S probably benign Het
Spint2 A G 7: 28,959,554 (GRCm39) probably benign Het
Sycp2 A T 2: 178,045,571 (GRCm39) D16E probably damaging Het
Tecpr2 T C 12: 110,902,854 (GRCm39) F860L probably benign Het
Tg A G 15: 66,560,724 (GRCm39) M1029V probably benign Het
Tmem126b C T 7: 90,118,830 (GRCm39) V153I probably benign Het
Uba2 A T 7: 33,847,022 (GRCm39) Y440N probably damaging Het
Vwa2 A G 19: 56,886,320 (GRCm39) E129G probably benign Het
Wapl A G 14: 34,413,639 (GRCm39) D167G probably benign Het
Zfp64 A G 2: 168,741,932 (GRCm39) F332S probably damaging Het
Zfp786 C T 6: 47,798,188 (GRCm39) R250H probably benign Het
Other mutations in Tab1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02686:Tab1 APN 15 80,033,031 (GRCm39) missense probably benign 0.05
memento UTSW 15 80,037,869 (GRCm39) missense probably damaging 0.96
Memoir UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R0085:Tab1 UTSW 15 80,040,094 (GRCm39) missense probably benign 0.00
R1341:Tab1 UTSW 15 80,044,315 (GRCm39) missense possibly damaging 0.86
R1835:Tab1 UTSW 15 80,032,497 (GRCm39) missense probably benign 0.42
R1907:Tab1 UTSW 15 80,037,869 (GRCm39) missense probably damaging 0.96
R3113:Tab1 UTSW 15 80,032,461 (GRCm39) missense probably benign 0.23
R3943:Tab1 UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R3944:Tab1 UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R4845:Tab1 UTSW 15 80,036,964 (GRCm39) missense probably damaging 1.00
R5345:Tab1 UTSW 15 80,034,014 (GRCm39) missense possibly damaging 0.48
R5696:Tab1 UTSW 15 80,032,930 (GRCm39) nonsense probably null
R6223:Tab1 UTSW 15 80,032,464 (GRCm39) missense probably damaging 1.00
R6242:Tab1 UTSW 15 80,039,971 (GRCm39) nonsense probably null
R6561:Tab1 UTSW 15 80,033,031 (GRCm39) missense probably benign 0.05
R7239:Tab1 UTSW 15 80,017,372 (GRCm39) missense probably benign 0.15
R7422:Tab1 UTSW 15 80,044,445 (GRCm39) missense probably benign 0.00
R7810:Tab1 UTSW 15 80,042,999 (GRCm39) missense possibly damaging 0.86
R7922:Tab1 UTSW 15 80,043,066 (GRCm39) missense possibly damaging 0.52
R7951:Tab1 UTSW 15 80,043,058 (GRCm39) missense probably damaging 0.98
R8007:Tab1 UTSW 15 80,042,969 (GRCm39) missense possibly damaging 0.94
R8037:Tab1 UTSW 15 80,044,471 (GRCm39) missense probably benign 0.08
R9221:Tab1 UTSW 15 80,034,754 (GRCm39) missense probably benign 0.00
R9273:Tab1 UTSW 15 80,041,904 (GRCm39) missense probably benign 0.00
R9590:Tab1 UTSW 15 80,040,097 (GRCm39) missense probably damaging 0.97
R9762:Tab1 UTSW 15 80,032,943 (GRCm39) missense probably damaging 0.96
Predicted Primers PCR Primer
(F):5'- TCTTTTCACCGGTGGGAAG -3'
(R):5'- AATGCAGTCTGTACTCAGGCC -3'

Sequencing Primer
(F):5'- AAGTTGAGGGCCCCTGATG -3'
(R):5'- AGTCTGTACTCAGGCCACAGC -3'
Posted On 2020-01-23